Sustainability
Global Biopharma Turns to ZAETHER to Drive Sustainability Plan
With the impact of climate change being felt increasingly around the world, many companies have embarked on sustainability initiatives intended not only to reduce their carbon footprint but also to save costs, attract investors, strengthen competitiveness, and meet regulatory requirements.
One such company is a global biopharmaceutical firm on the S&P 500 specializing in antiviral drugs. The company’s leaders had set ambitious goals to reduce greenhouse gas emissions, minimize water usage, reduce waste, achieve carbon net-zero operations, and fully transition to renewable energy at its development and production sites by 2030. To meet that target date, the firm needed to implement a sustainability plan in short order.